SGLT inhibitor adjunct therapy in type 1 diabetes

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

(2017) Satish K. Garg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

(2017) John R Petrie et al.   Lancet Diabetes & Endocrinology

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

(2017) Paresh Dandona et al.   Lancet Diabetes & Endocrinology

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

(2016) Chantal Mathieu et al.   DIABETES CARE

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

(2015) Arthur T. Sands et al.   DIABETES CARE

Efficacy and Safety of Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes

(2015) Robert R. Henry et al.   DIABETES CARE

Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

(2015) Kellee M. Miller et al.   DIABETES CARE

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)

(2015) T. R. Pieber et al.   DIABETES OBESITY & METABOLISM

Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison

(2015) J. A. McKnight et al.   DIABETIC MEDICINE

Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010

(2015) Shona J. Livingstone et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes

(2015) David Powell et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus

(2014) David ZI Cherney et al.   Cardiovascular Diabetology

Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

(2014) Robert R. Henry et al.   DIABETES CARE

Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial

(2014) Bruce A. Perkins et al.   DIABETES CARE

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Maintains β-Cell Function in Patients With Recent-Onset Latent Autoimmune Diabetes in Adults: One Year Prospective Study

(2014) Yunjuan Zhao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial

(2014) Kurt J Griffin et al.   Lancet Diabetes & Endocrinology

Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study

(2013) K.V.S. Hari Kumar et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus

(2012) G. Luippold et al.   DIABETES OBESITY & METABOLISM

Potential role of non-insulin adjunct therapy in Type 1 diabetes

(2012) P. George et al.   DIABETIC MEDICINE

The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes

(2012) L. Govan et al.   DIABETOLOGIA

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects

(2012) Ele Ferrannini et al.   Nature Reviews Endocrinology

Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study

(2012) Shona J. Livingstone et al.   PLOS MEDICINE

The use of metformin in type 1 diabetes: a systematic review of efficacy

(2010) S. Vella et al.   DIABETOLOGIA